So far we have demonstrated that 2i has a broad effect on UHRF1 and DNMT1 expression in cancer cells and that the effect of 2i on UHRF1 and DNMT1 expression is due to specific inhibition of MEK/ERK pathway. This evidence concerns the gene MAP2K7 and cancer.